US Bancorp’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.9K | Sell |
1,999
-179
| -8% | -$1.49K | ﹤0.01% | 3137 |
|
|
2026
Q1 | $18.3K | Sell |
2,178
-476
| -18% | -$5K | ﹤0.01% | 3157 |
|
|
2025
Q4 | $38.2K | Hold |
2,654
| – | – | ﹤0.01% | 2815 |
|
|
2025
Q3 | $25.6K | Sell |
2,654
-22
| -0.8% | -$195 | ﹤0.01% | 2973 |
|
|
2025
Q2 | $22K | Buy |
2,676
+179
| +7% | +$1.5K | ﹤0.01% | 3139 |
|
|
2025
Q1 | $17.9K | Buy |
2,497
+2,367
| +1,821% | +$17.6K | ﹤0.01% | 3223 |
|
|
2024
Q4 | $1K | Sell |
130
-2,352
| -95% | -$22.1K | ﹤0.01% | 3954 |
|
|
2024
Q3 | $26K | Sell |
2,482
-1,789
| -42% | -$21.8K | ﹤0.01% | 3034 |
|
|
2024
Q2 | $50K | Sell |
4,271
-2,151
| -33% | -$33.5K | ﹤0.01% | 2678 |
|
|
2024
Q1 | $135K | Sell |
6,422
-7,409
| -54% | -$132K | ﹤0.01% | 2211 |
|
|
2023
Q4 | $248K | Buy |
13,831
+13,586
| +5,545% | +$239K | ﹤0.01% | 1903 |
|
|
2023
Q3 | $4.03K | Hold |
245
| – | – | ﹤0.01% | 3497 |
|
|
2023
Q2 | $4.9K | Buy |
245
+37
| +18% | +$713 | ﹤0.01% | 3486 |
|
|
2023
Q1 | $3.93K | Sell |
208
-23
| -10% | -$509 | ﹤0.01% | 3602 |
|
|
2022
Q4 | $5.24K | Sell |
231
-62
| -21% | -$1.4K | ﹤0.01% | 3493 |
|
|
2022
Q3 | $8K | Sell |
293
-214
| -42% | -$6.35K | ﹤0.01% | 3454 |
|
|
2022
Q2 | $13K | Sell |
507
-419
| -45% | -$10.5K | ﹤0.01% | 3281 |
|
|
2022
Q1 | $31K | Buy |
926
+142
| +18% | +$3.94K | ﹤0.01% | 2840 |
|
|
2021
Q4 | $26K | Buy |
784
+154
| +24% | +$5.24K | ﹤0.01% | 2977 |
|
|
2021
Q3 | $26K | Buy |
630
+227
| +56% | +$8.17K | ﹤0.01% | 2995 |
|
|
2021
Q2 | $16K | Buy |
403
+218
| +118% | +$7.8K | ﹤0.01% | 3248 |
|
|
2021
Q1 | $6K | Hold |
185
| – | – | ﹤0.01% | 3461 |
|
|
2020
Q4 | $8K | Buy |
+185
| New | +$6.46K | ﹤0.01% | 3267 |
|
|
2020
Q1 | – | Sell |
-39
| Closed | -$2K | – | 3772 |
|
|
2019
Q4 | $2K | Hold |
39
| – | – | ﹤0.01% | 3497 |
|
|
2019
Q3 | $1K | Sell |
39
-15
| -28% | -$608 | ﹤0.01% | 3512 |
|
|
2019
Q2 | $3K | Hold |
54
| – | – | ﹤0.01% | 3397 |
|
|
2019
Q1 | $3K | Hold |
54
| – | – | ﹤0.01% | 3360 |
|
|
2018
Q4 | $2K | Buy |
54
+18
| +50% | +$1.06K | ﹤0.01% | 3427 |
|
|
2018
Q3 | $3K | Buy |
+36
| New | +$2.59K | ﹤0.01% | 3434 |
|
Other funds holding RGNX
RG
US Bancorp's RGNX Position: Q2 2026 in Review
US Bancorp reduced its Regenxbio (RGNX) stake by 8.2% in Q2 2026, selling an estimated $1.49K and leaving 1,999 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3137.
US Bancorp first reported a position in RGNX in Q3 2018 and has held it in 29 quarters since. The position peaked at $248K in Q4 2023. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- US Bancorp held 1,999 shares of Regenxbio worth $23.9K as of Q2 2026.
- US Bancorp sold 179 Regenxbio shares in Q2 2026, an estimated $1.49K.
- Regenxbio made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3137 holding.
- US Bancorp first reported a position in Regenxbio in Q3 2018 and has held it in 29 quarters since.
- US Bancorp's Regenxbio position peaked at $248K in Q4 2023.
- 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.